Nagmi Bano

According to our database, Nagmi Bano authored at least 1 paper in 2025.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2025

FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins.

Nagmi Bano, Shaban Ahmad, Dinesh Gupta, Khalid Raza

Comput. Biol. Medicine, 2025